<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Clinical research / Design of experiments / Clinical trial / Pharmacology / Case report form / Acute myeloid leukemia / Myelodysplastic syndrome / Ponatinib / Oncology / Medicine / Health
Date: 2014-12-09 19:34:53
Pharmaceutical industry
Clinical research
Design of experiments
Clinical trial
Pharmacology
Case report form
Acute myeloid leukemia
Myelodysplastic syndrome
Ponatinib
Oncology
Medicine
Health

Improving the treatment and the lives of patients with blood cancers through clinical trial research AUSTRALASIAN LEUKAEMIA AND LYMPHOMA GROUP Tr i a l s N e w s l e t t e r N o 5

Add to Reading List

Source URL: www.allg.org.au

Download Document from Source Website

File Size: 820,25 KB

Share Document on Facebook

Similar Documents

Lifebank_Logo_withTag-centered

Lifebank_Logo_withTag-centered

DocID: 1rakV - View Document

NIH Public Access Author Manuscript Clin Lymphoma Myeloma. Author manuscript; available in PMC 2009 November 30. NIH-PA Author Manuscript

NIH Public Access Author Manuscript Clin Lymphoma Myeloma. Author manuscript; available in PMC 2009 November 30. NIH-PA Author Manuscript

DocID: 1qxR7 - View Document

Microsoft Word - blood_cancer_gene_sanger_institute_release

Microsoft Word - blood_cancer_gene_sanger_institute_release

DocID: 1qeRh - View Document

Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

DocID: 1pn6V - View Document

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSNOriginal Article Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Resid

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSNOriginal Article Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Resid

DocID: 1oCtU - View Document